EXTENDED RELEASE PARENTERALS
Extended release capability for small molecules, peptides, and proteins
PULSE RELEASE PARENTERALS
Pulse release capability for vaccines and special delivery mechanisms
Delivery of therapeutic agents for treatment of otolaryngological diseases
ENTERIC-COATED ORAL POWDERS
A wide range of modified release options using format flexible powders
TASTE-MASKED ORAL POWDERS
Don’t sacrifice taste to get a dispersed solid oral dosage form
EXTENDED RELEASE ORAL SUSPENSIONS
Match extended release tablet performance in a suspension format
Orbis Biosciences has a diverse product portfolio to leverage where Precision Particle Fabrication® technology differentiates products.
We are focused on creating novel oral and injectable therapeutics to improve compliance and patient satisfaction. Our products address clinical needs and are at various stages of development. Many of the products are based on strategic partnerships with pharmaceutical companies. Products developed internally are positioned for co-development and licensing arrangements.
Kansas-based pharmaceutical technology company develops customized formulations and intellectual propertyDeal includes platforms that can be dosed in oral, injectable and otic (ear) formulationsAcquisition expands Adare’s [...]
LENEXA, KS – May 19, 2017 – Orbis Biosciences, Inc., is proud to announce the completion of its first-in-human clinical trial with ORB-101, its [...]
LENEXA, KS – December 8, 2017 – Orbis Biosciences, Inc., is a finalist for the FierceBiotech and FiercePharma (Fierce) Innovation Awards. Orbis Biosciences’ submission [...]